Malaria Drugs Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify
Malaria Drugs Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify
(Associated 22 671 96,000 All As Ashish Associated Boston Brigham COVID-19 Candice Carla Chicago Choi Clearly Cleveland Clinic. Desai Desai, Donald Dozens Dr. Drugs Earlier England Even French Global Harvard’s Health Hospital House In Institute. Its Jha Jha, Johnson Journal K. Lancet Lancet’s Malaria Mandeep May Medicine. Mehra New Nissen Organization Plattsburgh-Burlington: President Press Provided Sapan Several Steve Study Surgisphere Surgisphere. Surgisphere’s That The They Thursday. Thursday’s Trump WHO WPTZ White Women’s World ___ a able about access acknowledged, actual address after agreements. allegedly allowing also an and answer answers.” anxious. any are as audit authors authors. be because been benefit, besides blood but by can can’t chloroquine, citing client collaborations comments company, company’s concerns conclusion confidence confidentiality consistent continents. contributed controversial coronavirus could data data, data,” database death decided definite development, did director doctor done. don’t drugs earlier effectiveness effects, email errors errors. especially experts fast findings for founder, from full give good groups had harm,” has have heart higher himself hospitalized hospitals huge hydroxychloroquine immediately impact important improbable in included independent infection information involved involving irregularities is it its journal justifiable know known large leader leaders leading leading, led listed long longer malaria many materials. medicines more moving must need needed.” no no,” nor not notice notice, numbers numbers, observational of officials on one only or origination other outstanding overreact pace pandemic, pandemic.” patients patients, people phone positive potential pressure prevent preventing primary problem problems problems. promoted published published. publishing questioned questions raised reached. reaction really relied repeatedly report report). report, reportedly request research respond results resume. retract retracted retraction reviewed reviewers reviews rhythm rigorous risk safe safety said said, said. same saw say saying science, scientific scientists scientists. seems sent separate should showed shows side signal single six size, slow so some sources” sped staffers statement stop studies study study,” study." suggested system temporarily test, tested than that that’s the their there there. they this those though tied to to,” told too took topic treating try two unfortunate. unknown. unless up urgently use used using veracity verify very virus. vouch waiting want was way we week week, were what when who whose widely with work works,” would writers wrote. year yes you © “Based “I “Not “Part “This “We’re “You “institutional “is “the “there
Study on safety of Malaria Drugs for coronavirus retracted
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. © Provided by WPTZ Plattsburgh-Burlington:
Thursday’s retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.
The study leaders also retracted an earlier report using the same company’s database on blood pressure drugs published by the New England Journal of Medicine. That study